ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform

Study limitation reported by the research below: “The impact flag 'practice changing' is applied because this finding directly counters prior meta-analytic signals suggesting ARPIs increase fracture risk, but it is based on a secondary analysis rather than a primary pre-specified endpoint.”

Papers